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Abstract
Rationale—Although widely prescribed, little is known about selective serotonin reuptake
inhibitors (SSRIs) effects on social behavior and cerebrospinal fluid (CSF) monoamines in female
primates.
Objective—To determine the effects of sertraline on agonistic and affiliative behavior.
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Methods—21 adult female cynomolgus monkeys were housed in small, stable social groups,
trained to participate in oral dosing, and began a 5-week cumulative dose response study. Serial
doses of 0, 5, 10, 15, and 20 mg/kg of sertraline were administered orally for one week each.
Behavior was recorded daily during 10-minute observations before and 4 hours after dosing. On
the 7th day of dosing, circulating sertraline/desmethylsertraline and CSF monoamines/metabolites
were determined 4 hours after the last dose.
Results—At 20 mg/kg, circulating sertraline/desmethylsertraline was in the therapeutic range.
CSF 5-hydroxyindole acetic acid decreased 33% (p<0.05). Overall aggression, submission,
locomotion and time alone decreased, whereas affiliative behaviors (body contact, grooming)
increased (all p’s<0.05). Effects of sertraline on aggression and submission were social statusdependent, reducing aggression in dominants and submission in subordinates.
Conclusions—A clinically relevant oral dose of sertraline resulted in CSF metabolite changes
similar to those observed in patients, and altered the socioemotional behavior of female monkeys.
Changes in CSF 5-HT and dopamine are novel observations that may be sex-specific. The robust
effects of sertraline on aggression and affiliation may explain the efficacy of SSRIs on a range of
human behavioral pathologies that share the characteristics of increased aggression and decreased
sociality.
*
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Introduction
Data from the National Health and Nutrition Examination Survey 2005–2008 suggest that
antidepressants are the third most common prescription drug taken by Americans of all ages,
and the most frequently used by persons aged 18–44 years. About one in 10 Americans aged
12 years and over take antidepressant medication. Women are 2.5 times more likely than
men to take antidepressants and 23% of women aged 40–59 take antidepressants. More than
60% of Americans taking antidepressant medication have taken it for 2 years or longer; 14%
having taken the medication for 10 years or more. Less than one-third of Americans taking
one antidepressant medication and less than one-half of those taking multiple
antidepressants have seen a mental health professional in the past year (Pratt et al. 2011).
Side effects are common including sexual dysfunction (Segraves 2007). A selective
serotonin reuptake inhibitor (SSRI)- induced apathy syndrome has been identified (Barnhart
et al. 2004), and discontinuation of treatment can be difficult and uncomfortable, and is
referred to as the SSRI-discontinuation syndrome (Schatzberg et al. 2006).
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Anderson and colleagues (Anderson et al. 2005) used sertraline to study the time course of
the drug’s biological activity in the context of the commonly reported, though questioned
(Taylor et al., 2006), time lag for the clinical effects of the SSRIs. Few primate studies have
assessed sertraline effects on social behavior, however, one study examining treatments for
type 2 alcoholism showed that sertraline reduces alcohol intake and at the same time reduces
aggression (Higley et al. 1998). Other SSRIs have been evaluated for self-injurious and
stereotypic behavior in nonhuman primates (Fontenot et al. 2009). Given sertraline’s level of
use and its side effects, as well as the known involvement of the central 5-HT system in
most major classes of behavior, it is surprising that studies of the effects of SSRIs on broad
classes of social behavior in animal models, and particularly primate models, are not
available.
Here we report the effects of a commonly prescribed SSRI, sertraline HCl (Zoloft ®) on the
agonistic and affiliative behavior of socially-housed adult female cynomolgus monkeys
(Macaca fascicularis).

Methods
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Subjects
Twenty-two adult, reproductive-aged female cynomolgus monkeys were imported directly
from Indonesia (Institut Pertanian Bogor, Bogor, Indonesia) and quarantined in single cages
for one month. Following quarantine, the monkeys were housed in social groups (n = 4–5),
in indoor pens (3.05m × 3.05m × 3.05m), in a climate-controlled building, with 12/12 light/
dark, and water ad libitum. All monkeys were fed a Western-like diet containing 44% of
calories from fat and 0.29 mg/Cal cholesterol, approximately equal to a human consumption
of 500 mg cholesterol/2000 calories (Table 1). One animal had an adverse reaction
(hemorrhaging) to the sertraline and was removed from treatment leaving a final sample size
of 21. The incidence of bleeding in one animal is consistent with increased risk of bleeding
in patients treated with sertraline (Andrade et al. 2010).
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Experimental Design
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Eighteen months following formation of social groups, the monkeys were trained to run out
of their social group pens into a dosing cage where they were individually offered fat-free
vanilla pudding orally from a metal syringe. After consuming the pudding orally, the
monkeys were immediately released into their home cage. This initial dose-training was
completed in about two weeks, and a cumulative dose-response study of sertraline HCl
(Zoloft®) was initiated. Doses of 0, 5, 10, 15, and 20 mg/kg were administered orally in the
pudding for one week each at about 0800 hours each day. On day 7 of each dose and 4 hours
after dosing, the monkeys were sedated with 10–15 mg/kg ketamine HCl and blood samples
were taken to measure plasma levels of sertraline and desmethylsertraline. In addition,
cerebrospinal fluid (CSF) samples were taken every two weeks at the 0, 10, and 20 mg/kg
doses for determination of 5-hydroxy indole acetic acid (5-HIAA, a metabolite of 5-HT)
concentrations. CSF samples were taken by inserting a 22- gauge needle percutaneously into
the cisternal space while the ketamine-sedated animal was maintained in a lateral recumbent
position. Approximately 1–1.5 cc of spinal fluid was obtained and frozen at −70°C until
metabolite determinations were made.
Assays
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Sertraline and desmethylsertraline were analyzed by gas chromatography (NMS Labs,
Willow Grove, PA). An internal standard (8–chloroperphenazine) was added to 1.0 ml
serum aliquots that were buffered to pH 10 and extracted with toluene and back extracted
into dilute H2SO4. The acid was made basic and extracted with toluene. Sertraline and
metabolite were derivatized with butyric anhydride and analyzed on a DB-5 capillary
column, using an Agilent 6890 Gas Chromatograph with nitrogen selective detection. This
GC/NPD method was calibrated over a range of 1 to 200 ng/mL, with inter-assay precision
for sertraline/desmethylsertraline of 14/22% and 10/14% at 10 and 140 ng/mL, respectively.
Elution times were approximately 7.2 and 6.9 minutes for sertraline and desmethylsertraline,
respectively. 5-HIAA was analyzed using high-pressure liquid chromatography (HPLC)
with electrochemical detection as previously described (Shively et al. 2007). Intra- and
interassay coefficients of variation were <10%.
Behavior Observations
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Seven behaviors, aggression, submission, locomotion, passive body contact, grooming,
being groomed, and alone were recorded at 20-second intervals, in 10-minute group scans, 6
days/week, twice/day: Once in the morning prior to the daily dose at approximately 0800
hours (PRE), and again 4 hours post-dosing (POST) at approximately 1200 hours. During
the group scan, the 7 behaviors were recorded as 7 1-letter codes. One would be entered for
each 20 sec period for each monkey. Thus, every 20 sec the observer had to write down 1 of
7 codes for each of 4 monkeys. The number of intervals in which each behavior was
observed was divided by the total number of 20-second scans X 100, resulting in a percent
of 20-second scans in which the behavior was observed (Altmann 1974). Thus, a total of 30
samples of behavior, twice a day for 6 days (360 samples) were completed at each of 5
doses, for a total of 1800 samples of behavior. The specific aggressive behaviors recorded
included open mouth threat, stare threat, chase, charge, lunge, and cage shake display, the
frequency of which were summed for a total measure of aggression. The specific submissive
behaviors recorded included submissive present, fear grimace, lip smack, move away,
crouch, flee, scream, and scream threat, the frequency of which were summed for a total
measure of submission. Locomotion was recorded if the monkey traversed space. Alone was
recorded if the monkey was out of monkey arm’s reach of another monkey. Social status
was also determined weekly based on the direction of the outcome of agonistic interactions,
not on frequencies of behaviors. Social status hierarchies were linear and stable over the
course of the experiment. Operational definitions of all behaviors have been previously
Psychopharmacology (Berl). Author manuscript; available in PMC 2015 April 01.

Shively et al.

Page 4

NIH-PA Author Manuscript

published (Shively et al. 1986). For analysis weekly averages for the Pre-Dose and weekly
averages for the Post –Dose time periods were calculated. Interobserver reliability was
r≥0.92.
Statistical Analysis
The circulating levels of sertraline and desmethylsertraline, and CSF metabolite
concentrations were analyzed by a one-way repeated measures analysis of variance
(ANOVA). Initially, the behavioral data were analyzed by a 2 (dominant, subordinate) × 2
(pre, post-dosing) × 5 (doses) nested repeated measures ANOVA. ANOVA was also used
for follow up analyses of subsets of the data to clarify the effects found in the initial
analyses. The significance level was set at p=0.05.

Results
Circulating Levels of Sertraline and Desmethylsertraline and CSF Levels of 5-HIAA (Table
2)
Plasma levels of sertraline (F[3,57]=78.4, p=0.001) and desmethylsertraline (F[3,57]=79.7,
p=0.0002) rose significantly over the course of the study to levels comparable to those found
in patients treated with sertraline. 5-HIAA levels decreased with increasing sertraline
(F[2,40]=49.8, p<0.0001) confirming that the drug entered the central nervous system.
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Social Status and Time of Day Effects on Behavior
Social status is known to affect social behavior. Aggressive behavior (Figure 1A) was
higher in dominants than subordinates (Social Status F[1,19]=11.5, p=0.003), and
submissive behavior (Figure 1B) was lower in dominants than subordinates (Social Status
F[1,19]=38.8, p<0.0001).
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Circadian variations in behavior are common. In general, active behaviors decline in the
midday, and passive behaviors increase. Here, behavior was recorded daily before dosing
(PRE), at about 0800 hours, and four hours later after the monkeys received their daily dose
of sertraline, at about 1200 hours (POST). Aggressive behavior was lower after dosing than
before dosing (PrePost F[1,19]=19.8, p<0.0003), especially in dominant monkeys (Social
Status X PrePost interaction: F[1,19]=6.8, p<0.02) (Figure 1A), and submissive behavior
was lower after dosing than before dosing (PrePost F[1,19]=15.6, p<0.0009), especially in
subordinate monkeys (Social Status X PrePost interaction: F[1,19]=8.9, p<0.008) (Figure
1B). As expected, locomotion (Figure 1C) was lower after dosing than before dosing
(PrePost F[1,19]=6.6, p<0.02). Likewise, time alone (Figure 2C) was lower (PrePost
F[1,19]=20.1, p<0.0003), and sitting in passive body contact (Figure 2D) was higher after
dosing than before (PrePost F[1,19]=34.4, p=0.00001).
Effects of Sertraline on Behavior (main and interaction effects of Dose)
Aggression and Submission—Aggressive behavior decreased with increasing dose of
sertraline (Dose F[4,76]=3.7, p=0.009), but only in dominant monkeys (Social Status X
Dose interaction: F[4,76]=2.9, p<0.03) (Figure 1A). Submissive behavior also decreased
with increasing dose of sertraline (Dose F[4,76]=4.6, p=0.002), but only in subordinate
monkeys (Social Status X Dose interaction: F[4,76]=2.2, p<0.02). Because of the circadian
difference in submissive behavior reported above, a significant Social status X Dose X
PrePost interaction (F[4,76]=2.6, p=0.04) was observed (Figure 1B). Further analysis
comparing levels of submission pre- and post dose at the 0 versus 20 mg dose using
subordinate data only (2 X 2 ANOVA) revealed a significant main effect of dose
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(F[1,20]=5.7, p<0.03), confirming that sertraline reduced submissive behavior in
subordinates.
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Activity Levels (Figure 1C)—Locomotion decreased with increasing dose (Dose
F[4,76]=3.9, p<0.006).
Affiliation: Grooming and Being Groomed—Grooming (Figure 2B) increased with
increasing dose (Dose F[4,76]=3.3, p<0.02); the dose effect on being groomed (Figure 2A)
was not significant. The Dose X PrePost interaction was significant for grooming
(F[4,76]=3.2, p<0.02), and being groomed (F[4,76]=3.0, p=0.02). Visual inspection suggests
these interactions were due to the post-dose increase in grooming/being groomed at the 10
mg/kg dose (Figure 2B). The analysis was repeated without the 10 mg dose week, and a
main effect of dose was observed on grooming (Dose: (F[3,57]= 3.1, p=0.03) but not being
groomed.
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Time alone (Figure 2C) decreased with increasing dose (Dose F[4,76]=6.5, p=0.0001). The
Dose X PrePost interaction was significant (Dose X PrePost F[4,76]=4.4, p=0.003). This
may reflect a lack of difference between the pre- and post-dose observations during the 5
mg/kg week and the 15 mg/kg week or the widely disparate amounts of time spent alone at
the 10 mg dose. Further analysis comparing time alone pre- and post dose at the 0 versus 20
mg dose (2 × 2 ANOVA) confirmed that sertraline decreased time spent alone (main effect
of Dose F[1,19]=29.8, p<0.0001). The main effect of time of day was still significant
(PrePost F[1,19]=16.2, p=0.0007) and there was no dose by time of day interaction (Dose X
PrePost F[1,19]=0.23, p=0.63).
Sitting in passive body contact (Figure 2D) increased with increasing sertraline dose (Dose
F[4,76]=6.2, p=0.0002).

Discussion
Summary
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In the study reported here the administration of sertraline HCl had wide ranging effects on
the social behavior of adult female nonhuman primates. The circulating concentrations of
sertraline and desmethylsertraline demonstrate that the drug was successfully administered
by training the animals for oral dosing. The circulating concentrations of sertraline and
desmethylsertraline observed at the 20 mg/kg dose fell within the clinical range of efficacy
observed in patients (Reis et al. 2004). The CSF concentration changes in 5-HIAA
demonstrate that the sertraline reached the central nervous system and affected the 5-HT
system. The observed decline in CSF 5-HIAA levels was of the approximate magnitude
observed in prior studies of macaques (Anderson et al. 2005; Clarke et al. 1999) and is
consistent with the 40–60% declines typically seen in patients following sustained SSRI
treatment (Sheline et al. 1997). Thus, the observed decreases in agonistic behavior and
increases in affiliative behavior with sertraline administration appear to be directly due to
the drug.
It may be that SSRI efficacy in a range of human behavioral pathologies may be due, in part,
to their specific beneficial effects on aggression and affiliation. The best recognized
pathology affected by SSRIs is depression, which is often accompanied by anger, irritability
and aggression, as well as social isolation (Painuly et al. 2011). To the extent that the
observations made here are generalizable to human beings, it is possible that the
antidepressant effects of SSRIs in patients may be due as much to their effects on agonism
and affiliation as their effects on mood. There are some indications that SSRIs may be
helpful in reducing aggression and increasing positive social behaviors in dementias and
Psychopharmacology (Berl). Author manuscript; available in PMC 2015 April 01.
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autism spectrum disorder which support this hypothesis (Kolevzon et al. 2006; Pollock et al.
2007).
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Design Considerations
The purpose of this cumulative dose-response experiment was to document the effects of a
commonly prescribed SSRI on broad aspects of primate social behavior. The cumulative
dose-response design has both strengths and weaknesses. The strengths are that the design
mimics clinical care in that doses are typically adjusted without washout periods. Another
major strength is that studies can be completed with smaller sample sizes in shorter time
periods, both critical concerns in nonhuman primate studies. The weaknesses are that data
are only collected at each dose for 1 week and neurobiological effects of antidepressants
continue to change over a several week period, thus the effects of dose and duration cannot
be cleanly separated. However, many of the observed effects of sertraline involved
increasing magnitude of change in behavior with increasing dose and time which is another
indicator of a true effect of sertraline on behavior. The cumulative dose-response design also
does not include a placebo group which would provide an additional control and also
facilitate blinding behavioral technicians to treatment.
Translational Value of the Model
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The serotonergic system of macaques shares more similarities with human beings than
rodent systems with regard to nuclear organization, projection pathways, innervation
patterns, axonal morphologies, and 5-HT 1A receptor localization, making macaques
optimal models for investigations involving central nervous system 5-HT (Amaral and
Lavenex 2007; Azmitia and Gannon 1986; Buckmaster and Amaral 2001). The subjects
were chosen to model the age-sex group of human beings that are prescribed the most
antidepressants in the US. The monkeys were also fed a diet modeled on a typical Western
diet as macronutrient availability may alter neurobiological systems, and because the usual
laboratory monkey chow does not reflect either human consumption or feeding practices of
monkeys in the wild, and is replete with neurobiologically active isoflavones which alter 5HT neurotransmission in macaques (Shively et al. 2003; Stroud et al. 2006).
Social Modulation of Pharmacological Effects
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A wealth of studies demonstrate important effects of social factors e.g. social support, social
status, and social stress on depression. Because there is little information about the effects of
SSRIs on socially-housed primates, and changes in aggression levels have been shown
previously, we reasoned that in this initial study of socially-housed monkeys, it was prudent
to assign all animals in a social group to the same treatment (Higley et al. 1998; Carrillo et
al. 2009; Yanowitch and Coccaro 2011).
The effects on agonistic behavior were social status-dependent. Social status, determined by
the outcomes of agonistic interactions and not the frequency, was stable throughout this
experiment. Sertraline decreased aggressive behavior but only in dominants; subordinate
aggressive behavior was already low and remained low throughout the study. Likewise,
sertraline decreased submissive behavior but only in subordinates; submissive behavior of
dominants was already low and remained so throughout the study. It is likely that the
submissive behavior of subordinates decreased because the aggressive behavior of
dominants decreased. This is an important consideration because when monkeys change
social status from being subordinate to dominant, or vice versa, their agonist behavior
follows and becomes appropriate for their social status. This suggests that the effects of
sertraline, and perhaps other SSRIs, may be dependent on social variables, and could change
within a subject with changing social conditions. The fact that a social attribute of the
monkeys, social status, modified the effects of sertraline on behavior suggests that studying
Psychopharmacology (Berl). Author manuscript; available in PMC 2015 April 01.
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the effects of pharmacologic agents in social-living subjects may better predict the range of
effects that might be expected in human beings.
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The Role of Serotonin
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Among their many neurobiological effects, SSRIs make more serotonin (5-HT) available in
the synapse, altering central serotonergic neurotransmission. The observed decreases in CSF
5-HIAA following SSRI administration are presumed to be due to increased extracellular
levels of 5-HT causing increased autoreceptor-mediated inhibitory feedback on synthesis/
turnover of 5-HT. A wealth of preclinical and clinical data suggest that abnormally low
serotonergic activity results in increased aggression (Carrillo et al 2009; Moskowitz et al.,
2003). However, the majority of these studies necessarily rely either on cerebrospinal fluid
concentrations of 5-HIAA, or acute depletion of tryptophan, the percursor for 5-HT
synthesis in the brain, and the interpretation of such studies is not straightforward. For
example, CSF 5-HIAA concentrations reflect the sum of 5-HT metabolism in the CNS. CSF
5-HIAA may be low because 5-HT is low, which is how it is often interpreted, or it may be
low because 5-HT metabolism is low leaving more 5-HT available at the site of action, as in
the case of SSRI administration. Likewise, interpreting the neurobiological cause of
behavioral responses to acute depletion of a neurotransmitter that modulates many
neurotransmitter systems and processes in the brain is also fraught with difficulty. The
sudden removal of function of such a ubiquitous modulator is bound to have overt acute
effects that may be temporally bound. Increasing serotonin function in clinical populations
appears to reduce aggression, and SSRIs are prescribed for aggressive disorders. However,
whether increasing 5-HT decreases aggression in healthy individuals is less clear (Young et
al., 2013). Likewise, while excessive aggression associated with low 5-HT is incompatible
with friendly or affiliative behavior, it is also unclear whether raising 5-HT concentrations
actually promotes affiliation, or just creates a nonantagonistic situation that allows it (Young
et al., 2013).
Circadian Changes in Social Behavior
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Observations were done daily just prior to and 4 hours following sertraline dosing, at 0800
and 1200 hrs respectively. The purpose was to capture potential differences in acute versus
chronic changes in behavior, and also to document the accumulation of effects which might
begin to appear prior to daily dosing with the passage of time and increasing dose. However,
circadian rhythms in behavior complicate the interpretation of the observations. In general,
active behaviors (aggression, submission, locomotion) decline in the midday, and passive
behaviors (sitting in body contact) increase as a normal part of circadian cycles in behavior.
Here, main effects of time of day (i.e. PrePost) reflect consistent changes in behavior at
every dose including baseline (0 mg sertraline). These are reasonably interpreted as
circadian changes. However change in behavior pre- versus post-dosing that were different
at different doses required follow up analyses to determine whether there was a true effect of
sertraline on behavior. Follow up analyses confirmed effects of sertraline on submission (in
subordinates only), and grooming but not being groomed.
Unexpected Variations in Behavior After Dosing
At 10 mg/kg three unusual effects on behavior were observed after dosing: There was a
sharp increase in time spent grooming, which was accompanied by a sharp increase in time
spent being groomed, and decrease in time spent alone. Grooming is associated with reduced
urinary cortisol metabolites in the groomer, and reduced heart rate in the individual being
groomed, suggesting that it reduces physiological stress responses (Shutt et al. 2007; Boccia
et al. 1989). It may be that increased grooming by some of the monkeys was in response to a
transient agitation which is often reported early in treatment in patients.
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Summary and Future Research
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Thus, sertraline, a commonly prescribed SSRI, has significant effects on spontaneous
socioemotional behavior in female primates living in stable long-term social groups,
decreasing agonism and increasing affiliation, two major axes of social behavior. The effects
may well be amplified by all animals within a social group having the same treatment
(sertraline or placebo). However, since SSRIs are among the most prescribed drugs in the
US, it is important to consider their global effects on behavior and social interaction in small
groups such as families. The behavioral effects reported here reflect 5 weeks of exposure at
gradually increasing doses until a dose corresponding to a therapeutic dose in human beings
was reached. Since the majority of human beings who take antidepressants do so for more
than two years, it will be important to determine the longer term effects of commonly
prescribed antidepressants on social interaction. Likewise, since a large proportion of
antidepressant users are middle-aged women, it will be important to study these long-term
effects in women and female animal models.
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Figure 1. Aggression, Submission & Locomotion

The behavior units represent the percent of the scan observations in which the behavior was
observed. A. Aggressive behavior was higher in dominants than subordinates. Aggression
was lower after dosing (POST) than before dosing (PRE) in dominant monkeys. Aggressive
behavior decreased with increasing dose of sertraline in dominant monkeys. B. Submissive
behavior was higher in subordinates than dominants. Submissive behavior was lower after
dosing (POST) than before dosing (PRE) in subordinates. Submissive behavior decreased
with increasing dose of sertraline in subordinate monkeys. C. Locomotion was lower after
dosing (POST) than before (PRE), and decreased with increasing sertraline dose.
SUB=subordinate; DOM=dominant; PRE=prior to daily dosing; POST=4 hours after daily
dosing.
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Figure 2. Affiliation

The behavior units represent the percent of the scan observations in which the behavior was
observed. A. Being Groomed: There was a significant dose by time of day interaction,
however subsequent analysis showed no significant effect of sertraline. B. Grooming
increased with increasing dose. C. Alone: The frequency in which the monkeys were
observed alone was lower after (POST) than before (PRE) dosing. Time alone decreased
with increasing dose of sertraline. D. Sitting in passive body contact was higher after
(POST) than before (PRE) dosing, and increased with increasing dose of sertraline.
PRE=prior to daily dosing; POST=4 hours after daily dosing.
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Table 1

Diet Ingredients
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g/100 grams
Casein

6.00

Lactalbumin

6.00

Wheat Germ

3.00

NIH-PA Author Manuscript

Soy Protein

2.00

Wheat Flour, self-rising

35.00

Dextrin

9.00

Sucrose

7.00

Alphacel (non-nutrient bulk)

8.18

Lard

5.00

Beef Tallow

3.00

Butter, lightly salted

3.10

Safflower Oil

3.00

Dried Egg Yolk

1.80

Complete Vitamin Mix

2.50

Modified Ausman-Hayes Mineral Mix #2

5.00

Calcium Carbonate

0.400

Calcium Phosphate, Monobasic

0.02

Composition
Protein (% of calories)

17

Carbohydrate (% of calories)

46.5

Lipid (% of calories)

35.9

Saturated (% of calories)

14.4

Monounsaturated (% of calories)

12.8

Polyunsaturated (% of calories)

8.7

Cholesterol (mg/Calorie)*

0.17

Calcium (mg/1800 Calories)

268.9

Phosphorus (mg/1800 Calories)

271.1
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189.4 (11.61)

0.0 (0.0)

Desmethylsertraline

CSF 5-HIAA

0.0 (0.0)

0

Sertraline

ng/ml

41.0 (4.07)

29.8 (2.55)

5

115.9 (5.52)

71.5 (9.78)

58.3 (8.84)

10

Dose mg/kg

86.5 (8.60)

72.2 (15.24)

15

126.0 (9.45)

97.4 (16.97)

75.7 (13.75)

20
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Circulating Sertraline, Desmethylsertraline, and CSF 5-HIAA
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